Oculus Innovative Sciences Recalls Atrapro Antipruritic Hydrogel Due to Preservative Failure
Oculus Innovative Sciences is recalling Atrapro Antipruritic Hydrogel because stability testing showed insufficient free available chlorine, a preservative required to maintain product safety.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a theoretical risk related to preservative failure, which aligns with the 'Moderate' criteria for low-risk contamination or voluntary precautionary recalls without reported harm.
Plain-English summary
Oculus Innovative Sciences Inc is recalling 56,566 tubes of Atrapro Antipruritic Hydrogel, 1.5 oz. The product is a prescription-only professional sample intended to manage and relieve burning, itching, and pain associated with various dermatoses, including radiation dermatitis and atopic dermatitis.
The recall was initiated due to an out-of-specification result in stability testing. The product failed to meet the specification for free available chlorine (FAC), which functions as a preservative for the hydrogel. The 13-month stability test result showed 4 ppm FAC, while the required specification is greater than 10 ppm FAC.
The affected lots were distributed nationwide through one distributor in Pennsylvania. The specific lot numbers and expiration dates are: Lot 12A0012 (Exp 2/2013), Lot 12A0013 (Exp 2/2013), Lot 12A1116 (Exp 2/2013), Lot 12A1119 (Exp 2/2013), Lot 12B1144 (Exp 3/2013), Lot 12B1148 (Exp 3/2013), Lot 12C1157 (Exp 4/2013), Lot 12E190 (Exp 6/2013), Lot 12E194 (Exp 6/2013), Lot 12E198 (Exp 6/2013), Lot 12E202 (Exp 6/2013), Lot 12E208 (Exp 6/2013), and Lot 12E211 (Exp 6/2013). Consumers and healthcare providers should stop using the product and contact the manufacturer for instructions on return or disposal.
The recalled product
- Product
- Atrapro Antipruritic Hydrogel, 1.5 oz gel tube, 4 Net wt/ 1.5 oz.. RX only, Professional Sample, Not for Sale. Pre-printed tube: MS31071, Shelf carton: PL51091-08 Atrapro Antipruritic HydroGel is indicated to manage and relieve the burning, itching and pain experienced with
- Manufacturer
- Oculus Innovative Sciences Inc
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot 12A0012
- Exp 2/2013
- Lot 12A0013
- Exp 2/2013: Lot 12A1116
- Exp 2.2013
- Lot 12A1119
- Lot 12B1144
- Exp 3/2013
- Lot 12B1148
- Lot 12C1157
- Exp 4/2013
- Lot 12E190. Exp 6/2013
- Lot 12E194
- Exp 6/2013
- Lot 12E198
- Lot 12E202. Exp 6/2013
- Lot 12E208
- Lot 12E211
- Exp 6/2013.
Distribution
Related recalls
Same manufacturer · Oculus Innovative Sciences Inc
See all →- ModerateOculus Recalls Ceramax Skin Barrier Cream Professional Samples
FDA (Devices) · 2016-12-21
Same hazard · preservative failure
See all →- ModerateAkorn Recalls Fluticasone Nasal Spray Due to Preservative Failure
FDA (Drugs) · 2015-03-11
Other medical device recalls
- HighMedline C-Section Convenience Kits Recalled for Contaminated Components
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighMedline Recalls Neonatal Heated Wire Breathing Circuits Due to Thermal Damage
FDA (Devices) · 2026-09-02
- HighIMRIS ORT300 Operating Room Table Recalled for Mechanical Failure Risk
FDA (Devices) · 2026-09-02
- HighMedline Recalls 419 Surgical Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02